tm logo
L LUSIS
Live/Pending
PUBLISHED FOR OPPOSITION

on 05 Nov 2024

Last Applicant/ Owned by

3500 BREAKWATER COURT

HAYWARD

CA

94545

Serial Number

98458857 filed on 20th Mar 2024

Registration Number

N/A

Correspondent Address

Steven K. Lee

Steven K. Lee Donahue Fitzgerald LLP

Suite 2600

Oakland, CA 94612

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

L LUSIS

Injectable pharmaceuticals for treatment of anaphylactic reactions; Chemical reagents for medical purposes; Antibiotic tablets; Allergy tablets; Medicated water for the treatment of illnesses attributed to insufficient cellular energy; Medicated water for the treatment of allergies, cough, cold, flu, headache, pain; Medicated water for the treatment of infectious diseases, skin diseases and condit Read More

Classification Information


Class [005]
Pharmaceutical Products


Injectable pharmaceuticals for treatment of anaphylactic reactions; Chemical reagents for medical purposes; Antibiotic tablets; Allergy tablets; Medicated water for the treatment of illnesses attributed to insufficient cellular energy; Medicated water for the treatment of allergies, cough, cold, flu, headache, pain; Medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; Medicated water for the treatment of pain, nausea and muscle spasms; Medicated water-based solutions for treating skin infections and skin conditions; Medicated water for the treatment of gastrointestinal disorders; Antibiotic ointments; Anti-inflammatory ointments; Medicated ointments for treating dermatological conditions; Purified biochemical medical diagnostic reagents, namely, protein arrays, enzymes, and fluorescent dyes; Biochemical drugs for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; Diagnostic preparations for medical purposes; Chemico-pharmaceutical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory system; Chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory systems; Chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory system; Chemical reagents for medical or veterinary purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98458857

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 33723.00001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.15 -

Three circles

26.01.16 -

Circles touching or intersecting

26.01.21 -

Circles that are totally or partially shaded

27.03.01 -

Geometric figures forming letters or numerals, including punctuation

Legal History


Status DateAction Taken
05th Nov 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05th Nov 2024PUBLISHED FOR OPPOSITION
16th Oct 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28th Sep 2024APPROVED FOR PUB - PRINCIPAL REGISTER
27th Sep 2024ASSIGNED TO EXAMINER
11th Sep 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
15th Aug 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
14th Aug 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20th Mar 2024NEW APPLICATION ENTERED